| scholarly article | Q13442814 |
| P2093 | author name string | Bengt Haglund | |
| Mats Eliasson | |||
| Magnus Stenbeck | |||
| Måns Rosén | |||
| P2860 | cites work | Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers | Q28369584 |
| Swedish moist snuff and myocardial infarction among men. | Q34378977 | ||
| Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? | Q35824475 | ||
| Cardiac Arrhythmias Following Intravenous Nicotine: Experimental Study in Dogs | Q44868754 | ||
| Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke | Q46369394 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| P304 | page(s) | 618-622 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Scandinavian Journal of Public Health | Q7429963 |
| P1476 | title | Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden | |
| P478 | volume | 35 |
| Q57938337 | A systematic review on association between smokeless tobacco & cardiovascular diseases |
| Q37606703 | An epidemiologic review of smokeless tobacco health effects and harm reduction potential |
| Q61458244 | Association between metabolic effects and tobacco use in 60-year-old Swedish men |
| Q37789548 | Does dual use jeopardize the potential role of smokeless tobacco in harm reduction? |
| Q26995501 | Epidemiological evidence relating snus to health--an updated review based on recent publications |
| Q27027700 | Health risks related to dual use of cigarettes and snus - a systematic review |
| Q34140693 | Is there any association between use of smokeless tobacco products and coronary heart disease in Bangladesh? |
| Q36094863 | Non-Smoking Tobacco Affects Endothelial Function in Healthy Men in One of the Largest Health Studies Ever Performed; The Nord-Trøndelag Health Study in Norway; HUNT3. |
| Q50084235 | Risk of coronary heart disease among smokeless tobacco users: results of systematic review and meta-analysis of global data. |
| Q34179642 | Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study |
| Q54393393 | Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. |
| Q57921824 | Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis |
| Q34405020 | Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival |
| Q24597926 | Snus use and other correlates of smoking cessation in the Swedish Twin Registry |
| Q33371065 | Social differences in smoking and snuff use among Norwegian adolescents: a population based survey |
| Q33721437 | Socio-demographic, lifestyle and health characteristics among snus users and dual tobacco users in Stockholm County, Sweden |
| Q37821539 | Summary of the epidemiological evidence relating snus to health. |
| Q33454038 | Swedish snuff and incidence of cardiovascular disease. A population-based cohort study |
| Q48112602 | Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff. |
| Q42364526 | The Risk of Hypertension and Other Chronic Diseases: Comparing Smokeless Tobacco with Smoking |
| Q34038743 | The STAGE cohort: a prospective study of tobacco use among Swedish twins |
| Q34361356 | Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems |
| Q28276089 | Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis |
| Q34998151 | Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis |
| Q34283404 | Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies |
| Q34101084 | Who is using snus? - Time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population |
Search more.